Skip to content

Effect of Vitamin E+Selenium on Kidney Function in Controlled Hypotension

Assessment of Preventive Effect of Vitamin E +Selenium on Acute Kidney Injury Through NGAL in Patients Undergoing Controlled Hypotension During Neurosurgery Operations

Status
UNKNOWN
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01554345
Enrollment
60
Registered
2012-03-14
Start date
2011-06-30
Completion date
Unknown
Last updated
2012-03-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Kidney Injury

Brief summary

The purpose of this study is to determine whether Kidney injury happens in controlled hypotension during brain operations by using Neutrophil Gelatinase Associated Lipocalin ELISA Kit and if so, does VitaminE+Selenium prevent it

Detailed description

NGAL(Neutrophil Gelatinase Associated Lipocalin) is a 25KD protein which bounds with Gelatinase in Neutrophil granules.It is also expressed in epithelial cells of kidney tubules.NGAL increases in ischemic and toxic injuries of kidney. During controlled hypotension in brain operations injury to the kidneys might occur . This study is designed to assess this possibility and evaluate the effect of VitaminE+Selenium on prevention of this problem

Interventions

DRUGvitamin E +Selenium

vitamin E 400 IU once 8 hrs before operation selenium 150 mic once 8 hrs before operation

Sponsors

Tehran University of Medical Sciences
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* All patients who are candidate for brain surgery under controlled hypotension

Exclusion criteria

* Positive history of renal disease * Positive history of diabetes mellitus, CHF, HTN, Breast cancer, fever, leukocytosis

Design outcomes

Primary

MeasureTime frame
increased amount of urinary or serum NGAL after controlled hypotensionfrom 2 hours to 24 hours after controlled hypotension

Countries

Iran

Contacts

Primary ContactMahmoodreza Torkaman, resident
MRZTORKAMAN@yahoo.com0098 917 105 0954

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026